Patrys Ltd
ASX:PAB
Patrys Ltd
ASX:PAB
Price:
0.0075 AUD
7.14%
Market Closed
Updated:
May 17, 2024
Patrys Ltd
Income from Continuing Operations
|
Patrys Ltd
Income from Continuing Operations Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Patrys Ltd
ASX:PAB
|
Income from Continuing Operations
-AU$5.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
1%
|
|
|
Immutep Ltd
ASX:IMM
|
Income from Continuing Operations
-AU$40.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Income from Continuing Operations
-$73.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Income from Continuing Operations
$2.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Income from Continuing Operations
AU$30.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Income from Continuing Operations
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Patrys Ltd's Income from Continuing Operations?
Income from Continuing Operations
-5.1m
AUD
-5.1m
AUD
Based on the financial report for Dec 31, 2023, Patrys Ltd's Income from Continuing Operations amounts to -5.1m AUD.
What is Patrys Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
1%
1%
Over the last year, the Income from Continuing Operations growth was 17%. The average annual Income from Continuing Operations growth rates for Patrys Ltd have been -19% over the past three years , -53% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
